Differential effects of mixed lymphocyte reaction supernatant on human mesenchymal stromal cells

Experimental Hematology

Volumn 40, Issue 11, 2012, Pages 934-944

  Faßlrinner, Frederick ^a   Wobus, Manja ^a   Duryagina, Regina ^a   Müller, Katrin ^a   Stopp, Sabine ^a   Wehner, Rebekka ^b   Rauner, Martina ^a   Hofbauer, Lorenz C ^a,c   Schmitz, Marc ^b,c   Bornhäuser, Martin ^a,c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; COLONY FORMING UNIT M; CYTOPENIA; EFFECTOR CELL; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MICROENVIRONMENT; MIXED LYMPHOCYTE REACTION; PHENOTYPE; PRIORITY JOURNAL; SUPERNATANT;

CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; MESENCHYMAL STROMAL CELLS; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84867396336     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.07.011     Document Type: Article

References (45)

1. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Freund D., Bauer N., Boxberger S., et al. Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev 2006, 15:815-829.
3. Alakel N., Jing D., Muller K., Bornhauser M., Ehninger G., Ordemann R. Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133+ hematopoietic stem cells during ex vivo expansion. Exp Hematol 2009, 37:504-513.
4. Méndez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
5. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 2011, 208:421-428.
6. Zhao S., Wehner R., Bornhäuser M., Wassmuth R., Bachmann M., Schmitz M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev 2010, 19:607-614.
7. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
8. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
9. Holler E., Jobst K., Hahn J., et al. Secondary hematopoietic failure is a frequent complication of allogeneic stem cell transplantation. Onkologie 2002, 25(suppl 4):8-10. [abstract], Abstract 32.
10. Abrahamsen I.W., Sømme S., Heldal D., Egeland T., Kvale D., Tjønnfjord G.E. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005, 90:86-93.
11. Dominietto A., Raiola A.M., van Lint M.T., et al. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 2001, 112:219-227.
12. Wald A., Leisenring W., van Burik J.A., Bowden R.A. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997, 175:1459-1466.
13. Mori T., Nishimura T., Ikeda Y., Hotta T., Yagita H., Ando K. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression. Blood 1998, 92:101-107.
14. Yang L., Dybedal I., Bryder D., et al. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol 2005, 174:752-757.
15. Shono Y., Ueha S., Wang Y., et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010, 115:5401-5411.
16. Delisle J.-S., Gaboury L., Bélanger M.-P., Tassé E., Yagita H., Perreault C. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts. Blood 2008, 112:2111-2119.
17. Miettinen J.A., Pietilä M., Salonen R.J., et al. Tumor necrosis factor alpha promotes the expression of immunosuppressive proteins and enhances the cell growth in a human bone marrow-derived stem cell culture. Exp Cell Res 2011, 317:791-801.
18. Jordan W.J., Ritter M.A. Optimal analysis of composite cytokine responses during alloreactivity. J Immunol Methods 2002, 260:1-14.
19. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7:585-598.
20. Schäkel K., Kannagi R., Kniep B., et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 2002, 17:289-301.
21. Oswald J., Boxberger S., Jørgensen B., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
22. Seib F.P., Müller K., Franke M., et al. Engineered extracellular matrices modulate the expression profile and feeder properties of bone marrow-derived human multipotent mesenchymal stromal cells. Tissue Eng Part A 2009, 15:3161-3171.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
24. Hempel U., Hefti T., Kalbacova M., Wolf-Brandstetter C., Dieter P., Schlottig F. Response of osteoblast-like SAOS-2 cells to zirconia ceramics with different surface topographies. Oral Implants Res 2010, 21:174-181.
25. Jing D., Fonseca A.V., Alakel N., et al. Hematopoietic stem cells in co-culture with mesenchymal stromal cells-modeling the niche compartments in vitro. Haematologica 2010, 95:542-550.
26. Magnon C., Lucas D., Frenette P.S. Trafficking of stem cells. Methods Mol Biol 2011, 750:3-24.
27. Fibbe W.E., Pruijt J.F., Velders G.A., et al. Biology of IL-8-induced stem cell mobilization. Ann N Y Acad Sci 1999, 872:71-82.
28. Pruijt J.F., van Kooyk Y., Figdor C.G., Lindley I.J., Willemze R., Fibbe W.E. Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood 1998, 91:4099-4105.
29. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
30. North T.E., Goessling W., Walkley C.R., et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007, 447:1007-1011.
31. Majumdar M.K., Keane-Moore M., Buyaner D., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003, 10:228-241.
32. Teixidó J., Hemler M.E., Greenberger J.S., Anklesaria P. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest 1992, 90:358-367.
33. Wagner W., Wein F., Roderburg C., et al. Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp Hematol 2007, 35:314-325.
34. Wagner W., Wein F., Roderburg C., et al. Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44. Cells Tissues Organs 2008, 188:160-169.
35. Duque G., Huang D.C., Macoritto M., et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009, 27:550-558.
36. Cho H.H., Shin K.K., Kim Y.J., et al. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 2010, 223:168-177.
37. Lohmann M., Walenda G., Hemeda H., et al. Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS ONE 2012, 7:e37839.
38. Romieu-Mourez R., François M., Boivin M.N., Stagg J., Galipeau J. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J Immunol 2007, 179:1549-1558.
39. Rodrigues M., Griffith L.G., Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 2010, 1:32.
40. Spivak J.L., Barosi G., Tognoni G., et al. Chronic myeloproliferative disorders. Hematology Am Soc Hematol Educ Program 2003, 200-224.
41. Rougier F., Cornu E., Gachard N., Praloran V., Denizot Y. Tumour necrosis factor-alpha (TNFalpha) stimulates the growth of human bone marrow stromal cells. Mediators Inflamm 1997, 6:233-235.
42. Chan J.L., Tang K.C., Patel A.P., et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 2006, 107:4817-4824.
43. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE 2010, 5:e10088.
44. Auletta J.J., Deans R.J., Bartholomew A.M. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood 2012, 119:1801-1809.
45. Bartsch K., Al-Ali H., Reinhardt A., et al. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation 2009, 87:217-221.